HIV RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS

被引：213

作者：

DECLERCQ, E

机构：

[1] Rega Institute for Medical Research, Katholieke Universiteit Leuven

来源：

BIOCHEMICAL PHARMACOLOGY | 1994年 / 47卷 / 02期

关键词：

HUMAN IMMUNODEFICIENCY VIRUS; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS-DRUG RESISTANCE; DIDEOXYNUCLEOSIDES; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; COMBINATION CHEMOTHERAPY;

D O I：

10.1016/0006-2952(94)90001-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：155 / 169

页数：15

共 120 条

[1] PERSISTENCE OF AZIDOTHYMIDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA GENOTYPES IN POSTTREATMENT SERA [J].

ALBERT, J ;

WAHLBERG, J ;

LUNDEBERG, J ;

COX, S ;

SANDSTROM, E ;

WAHREN, B ;

UHLEN, M .

JOURNAL OF VIROLOGY, 1992, 66 (09) :5627-5630

[2]

BABA M, 1991, MOL PHARMACOL, V39, P805

[3]

BABA M, 1993, BIOCHEM PHARMACOL, V45, P2507

[4] POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY 5-ETHYL-6-PHENYLTHIOURACIL DERIVATIVES THROUGH THEIR INTERACTION WITH THE HIV-1 REVERSE-TRANSCRIPTASE [J].

BABA, M ;

DECLERCQ, E ;

TANAKA, H ;

UBASAWA, M ;

TAKASHIMA, H ;

SEKIYA, K ;

NITTA, I ;

UMEZU, K ;

NAKASHIMA, H ;

MORI, S ;

SHIGETA, S ;

WALKER, RT ;

MIYASAKA, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2356-2360

[5] HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].

BABA, M ;

TANAKA, H ;

DECLERCQ, E ;

PAUWELS, R ;

BALZARINI, J ;

SCHOLS, D ;

NAKASHIMA, H ;

PERNO, CF ;

WALKER, RT ;

MIYASAKA, T .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381

[6] OXATHIIN CARBOXANILIDE, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REPRODUCTION [J].

BADER, JP ;

MCMAHON, JB ;

SCHULTZ, RJ ;

NARAYANAN, VL ;

PIERCE, JB ;

HARRISON, WA ;

WEISLOW, OS ;

MIDELFORT, CF ;

STINSON, SF ;

BOYD, MR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6740-6744

[7] TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED CELLS WITH COMBINATIONS OF HIV-1-SPECIFIC INHIBITORS RESULTS IN A DIFFERENT RESISTANCE PATTERN THAN DOES TREATMENT WITH SINGLE-DRUG THERAPY [J].

BALZARINI, J ;

KARLSSON, A ;

PEREZPEREZ, MJ ;

CAMARASA, MJ ;

TARPLEY, WG ;

DECLERCQ, E .

JOURNAL OF VIROLOGY, 1993, 67 (09) :5353-5359

[8] KNOCKING-OUT CONCENTRATIONS OF HIV-1-SPECIFIC INHIBITORS COMPLETELY SUPPRESS HIV-1 INFECTION AND PREVENT THE EMERGENCE OF DRUG-RESISTANT VIRUS [J].

BALZARINI, J ;

KARLSSON, A ;

PEREZPEREZ, MJ ;

CAMARASA, MJ ;

DECLERCQ, E .

VIROLOGY, 1993, 196 (02) :576-585

[9]

BALZARINI J, 1991, J BIOL CHEM, V266, P21509

[10] INTRACELLULAR METABOLISM AND MECHANISM OF ANTIRETROVIRUS ACTION OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, A POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS COMPOUND [J].

BALZARINI, J ;

ZHANG, H ;

HERDEWIJN, P ;

JOHNS, DG ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1499-1503

← 1 2 3 4 5 6 7 8 9 10 →